Showing results (1201-1210 of 1,376) with videos related to

Sort By:
Pageof 138
Iscience|August 16, 2022
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathwaysFangzhu Zhao, Celina Keating, Gabriel Ozorowski, et al.
Science (New York, N.Y.)|July 19, 2011
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 bindingJohannes F Scheid, Hugo Mouquet, Beatrix Ueberheide, et al.
Science Translational Medicine|September 22, 2017
Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktailBoris Julg, Po-Ting Liu, Kshitij Wagh, et al.
Journal of Medicinal Chemistry|November 15, 2002
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 3. Structure activity relationships at C3(1,2)Eddy W Yue, C Anne Higley, Susan V DiMeo, et al.
The Journal of Experimental Medicine|August 27, 2014
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaquesMasashi Shingai, Olivia K Donau, Ronald J Plishka, et al.
Plos Pathogens|March 28, 2022
A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparumNathan Beutler, Tossapol Pholcharee, David Oyen, et al.
Clinical and Vaccine Immunology : CVI|August 20, 2011
Establishment of a new human pneumococcal standard reference serum, 007spD Goldblatt, B D Plikaytis, M Akkoyunlu, et al.
Nature Communications|May 15, 2021
Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpointNathalie M Schmidt, Peter A C Wing, Mariana O Diniz, et al.
Pageof 138